Journal scan
Proton pump inhibitors should not be used for longer than necessary, study finds
Research compares death rates of people taking PPIs with those taking H2 blockers
Research compares death rates of people taking PPIs with those taking H2 blockers
Proton pump inhibitors (PPIs) are a group of drugs whose main action is a pronounced and long-lasting reduction of stomach acid production. They are prescribed for prevention and treatment of acid-related conditions, such as heartburn and stomach ulcers. PPIs are widely used either as prescription or over-the-counter drugs.
Several previous studies have suggested that taking PPIs is associated with serious adverse events, including cardiovascular disease (CVD), acute kidney injury, chronic kidney disease (CKD), dementia, pneumonia, gastric cancer, Clostridium difficile infections and osteoporotic fractures.
- RELATED: Acid reflux treatment drugs linked
Want to read more?
Unlock full access to RCNi Plus today
Save over 50% on your first three months:
- Customisable clinical dashboard featuring 200+ topics
- Unlimited online access to all 10 RCNi Journals including Nursing Older People
- RCNi Learning featuring 180+ RCN accredited learning modules
- NMC-compliant RCNi Portfolio to build evidence for revalidation
- Personalised newsletters tailored to your interests
Already registered or subscribed? Log in
This article is not available as part of an institutional subscription. Why is this?
